Skip to main content
. Author manuscript; available in PMC: 2009 May 4.
Published in final edited form as: Leukemia. 2008 Jul 10;22(10):1917–1924. doi: 10.1038/leu.2008.188

Table 2.

Differential expression of the 16 candidate genes according to the COO classification

Overexpressed in GC Gene symbol Fold-change GC/ABC 95% Cl p-value

MME 23.64 (12.23–45.69) p<10−13
MYBL1 11.06 (6.21–19.71) p<10−11
ANKRD15 4.29 (2.68–6.88) p<10−7
LMO2 3.32 (1.83–6.04) p<10−3
BCL7A 2.45 (1.44–4.17) p<10−2
CSTA 2.25 (1.27–3.98) p<10−2
LPP 1.80 (1.29–2.51) p<10−3
RAFTLIN 1.68 (1.19–2.38) p<10−2
VNN2 1.67 (1.12–2.50) p=0.01
SYPL 1.65 (1.21–2.23) p<10−2
PLAU 1.32 (0.91–1.90) NS

Overexpressed in ABC Fold-change ABC/GC 95% Cl p-value

FOXP1 2.70 (1.86–3.90) p<10−5
PDE4B 1.77 (1.37–2.28) p<10−4
JAK2 1.58 (1.19–2.08) p<10−2
APOBEC3G 1.39 (1.03–1.87) p=0.03
RAB33A 1.36 (0.83–2.23) NS

This Table indicates the relative expression of the genes in the GC and ABC subgroups defined by hierarchical clustering. The statistical difference between the two groups was assessed with Student t-tests. It is important to note that MME, MYBL1, LMO2 were used to classify the samples, and were thereby expected to show a strong correlation with the COO classification. PLAU and RAB33 gene expression levels were not significantly correlated with the COO classification.